Is Proassurance Corporation Pra Stock A Buy Or Sell Price At 24.52 Down 0.30 20260406 Is Genasys Gnss Stock Ready To Move Price At 1.80 Down 0.28 20260406 Will General Gd Stock Outperform S P 500 Price At 349.06 Down 0.01 20260406 DeepSeek AI Model Rattles US Tech Stocks Boosts SafeHaven Currencies Freedom Broker Lifts Bank of America Price Target Following Strong FirstQuarter Performance Jim Cramer Advises FirstTime Homebuyers to Expect Market Corrections and Adopt a 5050 StockIndex Strategy AI Washing Gains Traction as UK Firms Rebrand Automation as Artificial Intelligence UK Police Chiefs Push for Social Media Block for Under16s Regulatory Risks for Tech Firms OpenAI Explores Landmark IPO Potentially Rivaling SpaceX in Size Pathward Financial CASH Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly GRDX Q3 2024 Earnings Significant EPS Miss Amidst Operational Challenges SFIX Q1 2026 Earnings BetterThanExpected Loss Provides Some Relief CHMG Q1 2026 Earnings EPS Surpasses Estimates by Over 15 Amid Steady Performance Prairie Operating Co PROP Q1 2026 Earnings Wide EPS Miss Amid No Revenue SKYE Q1 2026 Earnings EPS Misses Estimates Amid No Revenue Shares Edge Higher Duke Energy Preferred DUKB Edges Higher Holding Above Key Support Level Sila Realty Trust SILA Holds Steady Near 3020 Testing Key Support and Resistance Levels GDL Fund GDL Holds Steady at 847 as Consolidation Persists Neuronetics STIM Holds at 122 as Stock Consolidates Near Key Support ATRenew Inc RERE Faces Selling Pressure as Shares Retreat 5 Key Support in Focus Chemed Corp CHE Holds Steady Near Support Amid Narrow Trading Range Monolithic Power Systems MPWR Surges 46 Breaking Past Key Resistance Levels AECOM ACM Climbs 265 as Infrastructure Bet Drives Investor Enthusiasm Live Oak Acquisition Corp V LOKV Holds Steady Near Support as Investors Await Development Unifi Inc UFI Edges Higher Testing Resistance After a Constructive Session Lenovo Shares Surge Over 15 as AI Revenue Nearly Doubles in Record Earnings Wipro Q1 2026 Earnings EPS Misses Estimates Amid Challenging Demand Environment OS Therapies OSTX Tests Support as Shares Decline Nearly 5